MedPage Today (3/9, Monaco) reports, “Gabapentin (Neurontin, Gralise) may be a useful aid for people suffering from alcohol use disorder (AUD),” research indicated. During the “16-week trial, 27% adults who met the criteria for AUD, and who received up to 1,200 mg a day of gabapentin, had no heavy drinking days versus only 9% of those on placebo.” the study revealed. The findings were published online March 9 in JAMA Internal Medicine.
Psychiatric News (3/9) reports the study “enrolled 96 adults who met the DSM-5 diagnosis for AUD, including alcohol withdrawal.”
Related Links:
— MedPage Today (requires login and subscription)